Murali Dharan, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Danville, CANPI 1336143882
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,400 of the $23,640 with a category attached, or 69.4%. Atricure, Inc. accounts for 78.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $20,191 and has fallen 87.8% since, to $2,466 in 2025.
Across 59 payments — averaging $400.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$18K
- Abbott$1K
- Intuitive Surgical$1K
- Medtronic$1K
- Artivion, Inc.$699
- Edwards Lifesciences$184
- plus $722 from 10 others
What the payments were for
- Consulting fees$16,40069%
- Travel & lodging$4,42619%
- Food & beverage$2,0439%
- Education$7713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 25 | $18,449 |
| Abbott | 4 | $1,256 |
| Intuitive Surgical | 4 | $1,165 |
| Medtronic | 10 | $1,165 |
| Artivion, Inc. | 3 | $699 |
| Edwards Lifesciences | 2 | $184 |
| Johnson & Johnson | 1 | $125 |
| Livanova USA, Inc. | 1 | $125 |
| Mylan Specialty L.p. | 1 | $124 |
| Heartflow, Inc. | 1 | $121 |
| Corcym Inc | 1 | $70 |
| Pacira Pharmaceuticals Incorporated | 1 | $65 |
| Boston Scientific | 2 | $50 |
| Octapharma USA, Inc. | 1 | $16 |
| Abiomed | 1 | $14 |
| CSL Behring | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,146
- TRICLIP$1,071
- VITALFLOW CONSOLE$835
- Cardiac non-SynerGraft$699
- Mitra Clip system$176
- Octopus$170
- XARELTO$125
- Perceval$125
- Yupelri$124
How this compares
$23,640 in reported general payments places this provider in the 80th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.
See all thoracic surgery (cardiothoracic vascular surgery) providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 33 | $223 |
| Amiodarone Hcl | 13 | $188 |
| Potassium Chloride | 22 | $93 |
| Atorvastatin Calcium | 17 | $91 |
| Famotidine | 20 | $85 |
| Metoprolol Tartrate | 26 | $73 |
| Metformin Hcl | 11 | $21 |
| Furosemide | 21 | $19 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Danville
- Thomas FogartyPortola Valley$3.7M
- Steven GundryPalm Springs$1.6M
- Armin KiankhooySaint Helena$941K
- Ara KlijianMurrieta$916K
- Gregory FontanaThousand Oaks$875K
- Gansevoort DunningtonSaint Helena$764K
- Wilson TsaiWalnut Creek$680K
- Fernando FleischmanLos Angeles$608K
- Harmik SoukiasianLos Angeles$577K
- Ali KhoynezhadLong Beach$476K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.